Summary
Centene Corporation's (CNC) 2023 10-K filing reveals a year of significant strategic repositioning, marked by substantial divestitures and a focus on profitable growth through its core government-sponsored healthcare programs. The company reported total revenues of $154.0 billion, a 7% increase year-over-year, driven primarily by strong performance in its Medicaid and Commercial segments, particularly the Health Insurance Marketplace (Ambetter Health). Despite a 2% increase in overall membership to 27.5 million, the company experienced a decline in its Medicare membership. Financially, Centene demonstrated improved profitability, with diluted EPS of $4.95, a significant increase from $2.07 in the prior year, and adjusted diluted EPS of $6.68, up over 15%. This improvement was achieved despite $529 million in impairment charges, largely related to divestitures and real estate optimization. The company also generated strong operating cash flows of $8.1 billion, highlighting operational efficiency. Key strategic moves in 2023 included the completion of several divestitures (Operose Health, Circle Health) as part of its Value Creation Plan, alongside $1.6 billion in share repurchases. Looking ahead, Centene is focused on margin expansion, leveraging its scale, and navigating evolving regulatory landscapes, particularly within the Medicare and Medicaid programs.
Financial Highlights
55 data points| Revenue | $154.00B |
| Cost of Revenue | $3.56B |
| Gross Profit | $17.64B |
| SG&A Expenses | $12.56B |
| Operating Expenses | $151.07B |
| Operating Income | $2.93B |
| Interest Expense | $725.00M |
| Net Income | $2.70B |
| EPS (Basic) | $4.97 |
| EPS (Diluted) | $4.95 |
| Shares Outstanding (Basic) | 543.32M |
| Shares Outstanding (Diluted) | 545.70M |
Key Highlights
- 1Total revenues grew 7% year-over-year to $154.0 billion, driven by strong performance in Medicaid and the Health Insurance Marketplace.
- 2Diluted Earnings Per Share (EPS) surged to $4.95, a substantial increase from $2.07 in the prior year, with adjusted diluted EPS growing over 15% to $6.68.
- 3Operating cash flow remained robust at $8.1 billion, demonstrating strong cash generation capabilities.
- 4Centene completed several strategic divestitures in 2023, including Operose Health and Circle Health, as part of its Value Creation Plan aimed at streamlining operations and focusing on core business areas.
- 5Share repurchases totaled $1.6 billion in 2023, reflecting the company's commitment to returning capital to shareholders.
- 6Medicaid segment revenue increased 8%, while the Commercial segment saw a significant 43% revenue increase, largely due to growth in the Health Insurance Marketplace (Ambetter Health).
- 7The company established a $250 million premium deficiency reserve for its 2024 Medicare Advantage business, reflecting anticipated revenue impacts from star rating changes and CMS pricing adjustments.